Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.
about
Epigenetically regulated Fibronectin leucine rich transmembrane protein 2 (FLRT2) shows tumor suppressor activity in breast cancer cells.Levels of DNA Methylation Vary at CpG Sites across the BRCA1 Promoter, and Differ According to Triple Negative and "BRCA-Like" Status, in Both Blood and Tumour DNA.Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes.Association of BRCA1 promoter methylation with sporadic breast cancers: Evidence from 40 studies.DNA methylation modifies the association between obesity and survival after breast cancer diagnosis.Increased Proportion of Variance Explained and Prediction Accuracy of Survival of Breast Cancer Patients with Use of Whole-Genome Multiomic Profiles.The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies.Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer.Efficiency of methylated DNA immunoprecipitation bisulphite sequencing for whole-genome DNA methylation analysis.Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.Obtaining high quality transcriptome data from formalin-fixed, paraffin-embedded diagnostic prostate tumor specimens.Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008.Aberrant HOXA10 Methylation in Patients With Common Gynecologic Disorders: Implications for Reproductive Outcomes.CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression.Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.
P2860
Q33671991-414B971F-8CD7-4B8B-9094-D3414087F2D0Q36087198-E15DC46F-9313-4BE2-B460-822C4359D617Q36286909-C5E2CAA7-7B48-4380-9B0B-252FF5CBBC2EQ36353571-D81DCF37-3425-4C6C-A976-6D13366C2EE1Q36961072-6EB4AE9A-E92F-4E3E-AB73-6C76F4FBCA8BQ37076838-DE8561A8-1D63-46D5-8596-2A690D045813Q37395627-EE42A3BD-6722-4D2C-B2DC-A8F742013B07Q37631676-4450274B-57FA-49A4-98F5-0C965F839363Q39707073-B27F2D9D-A778-413C-B800-B9EE25694649Q47797030-6F0B3769-050E-4334-BEB2-CF82BDFA6F4AQ48231387-A85FE867-76DF-485E-BBFC-2EB53105C184Q50055284-55D9EF5B-9A22-4367-9C95-D5A618D33DF8Q50932361-26762F27-31F9-4F59-8CBF-D2E5F9FA815BQ55168635-41595F89-D7E5-4884-9755-5ACFAC5B6D0DQ55332393-E8289309-4D68-4CD2-AA4C-274221546756
P2860
Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.
@en
type
label
Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.
@en
prefLabel
Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.
@en
P2093
P2860
P50
P356
P1476
Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.
@en
P2093
Balázs Győrffy
Giulia Bottai
Gyöngyi Munkácsy
Jan Budczies
Laura Paladini
Libero Santarpia
P2860
P356
10.1002/IJC.29684
P577
2015-07-14T00:00:00Z